연혁
2018
6
Dual Listing of OTC in USA exchange
2017
Aug
Listing in the Canada Stock Exchange (CSE)
2016
Oct
Contracted joint venture for FMD Vaccine production with Pharos Vaccine, Korea
Oct
Bio-similar and a FMD Vaccine joint factory project with ORNA, Turkey
Oct
Started Production of hair production containing 5 kinds of growth factors
Jul
Final discussing a Bio-similar joint factory project with Royan Group, Iran
Aug
Established Biopharma-Switzerland in Zurich, Switzerland (main shareholder)
2015
Sep
Completed capital increase with consideration (issued total 3,158,887 shares)
Jan
Agreed with Biocurepharm-C company(Turkey) for joint development of Ranibizumab
2012
Jan
Established Biocurepharm-MG in Singapore with Macauley Gehler
Aug
Attracted FDI USD500Mil from Macauley Gehler, Singapore
2011
Mar
Completed joint development of a detection kit of breast cancer (clinical test started)
2007
Dec
Achieved export of USD 4.5 million
2006
Nov
Awarded the national export tower of USD 1 million
2005
Aug
Company founded (Paid-in capital of USD 50,000)